close

Fundraisings and IPOs

Date: 2017-05-02

Type of information: Series A financing round

Company: Exocobio (Republic of Korea)

Investors: SBI Investment (Republic of Korea) Atinum Investment (Republic of Korea) ID Ventures (Republic of Korea) Dt&Investment (USA - PA)

Amount: $11 million

Funding type: series A financing round

Planned used:

  • ExoCoBio is a venture-backed startup that develops exosome-based cosmeceuticals and biopharmaceuticals for skin and tissue regeneration. The company  was established in January 2017 by reputable exosome scientists and experienced management to develop innovative biopharmaceuticals and cosmeceuticals based on stem cell-derived exosomes.
  • ExoCoBio has raised a total of approximately US $13.5 million and is planning to establish R&D and GMP facilities to commercialize exosome-based cosmeceuticals. In the long term, ExoCoBio plans to develop innovative exosome-based biopharmaceuticals for major diseases with unmet medical needs.
 

Others:

  • • On May 2, 2017, ExoCoBio announced that it has raised a total of US $11 million in its Series A funding round, within four months of its establishment.  The investment was secured from top tier South Korean venture capital firms such as SBI Investment, Atinum Investment, ID Ventures, and Dt&Investment.
 

Therapeutic area: Autoimmune diseases - Dermatological diseases

Is general: Yes